Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study (Q37561580)
Jump to navigation
Jump to search
scientific article published on 09 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study |
scientific article published on 09 August 2016 |
Statements
1 reference
Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study (English)
1 reference
L Cai
1 reference
J Gu
1 reference
J Zheng
1 reference
M Zheng
1 reference
G Wang
1 reference
L-Y Xi
1 reference
F Hao
1 reference
X-M Liu
1 reference
Q-N Sun
1 reference
Y Wang
1 reference
W Lai
1 reference
H Fang
1 reference
Y-T Tu
1 reference
Q Sun
1 reference
J Chen
1 reference
X-H Gao
1 reference
Y Gu
1 reference
H D Teixeira
1 reference
J-Z Zhang
1 reference
M M Okun
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference